Cargando…

Advances in Molecular Pathophysiology and Targeted Therapy for Cushing’s Disease

SIMPLE SUMMARY: Cushing’s disease is caused by autonomous adrenocorticotropic hormone (ACTH) produced by corticotroph pituitary neuroendocrine tumors, leading to cortisol over-production in the adrenal glands. Cushing’s disease presents with a variety of clinical features, ranging from overt to subt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takayasu, Shinobu, Kageyama, Kazunori, Daimon, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857185/ https://www.ncbi.nlm.nih.gov/pubmed/36672445 http://dx.doi.org/10.3390/cancers15020496

Ejemplares similares

Acute mesenteric ischemia and hepatic infarction after treatment of ectopic Cushing’s syndrome
por: Takayasu, Shinobu, et al.
Publicado: (2017)

Progression of Hypopituitarism and Hypothyroidism after Treatment with Pembrolizumab in a Patient with Adrenal Metastasis from Non-small-cell Lung Cancer
por: Yamagata, Satoshi, et al.
Publicado: (2019)

Inhibitory effects of a selective Jak2 inhibitor on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT20 cells
por: Asari, Yuko, et al.
Publicado: (2017)

Biochemical Evaluation by Confirmatory Tests after Unilateral Adrenalectomy for Primary Aldosteronism
por: Murasawa, Shingo, et al.
Publicado: (2023)

SUN-291 Presence of Aberrant Adrenocorticotropic Hormone Precursors in Two Cases of McCune- Albright Syndrome
por: Yamagata, Satoshi, et al.
Publicado: (2020)

Hypothalamic Regulation of Corticotropin-Releasing Factor under Stress and Stress Resilience
por: Kageyama, Kazunori, et al.
Publicado: (2021)

Eosinophil counts can be a predictive marker of immune checkpoint inhibitor-induced secondary adrenal insufficiency: a retrospective cohort study
por: Takayasu, Shinobu, et al.
Publicado: (2022)

A Case of Thyrotoxicosis due to Simultaneous Occurrence of Subacute Thyroiditis and Graves' Disease
por: Kageyama, Kazunori, et al.
Publicado: (2018)

Advancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly and Cushing Disease Paradigms
por: Mooney, Michael A., et al.
Publicado: (2016)

The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications
por: Isidori, Andrea M., et al.
Publicado: (2015)

The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
por: Barbot, Mattia, et al.
Publicado: (2019)

Recent advances in the medical treatment of Cushing’s disease
por: Fleseriu, Maria
Publicado: (2014)

Evaluation of the (1–24) adrenocorticotropin stimulation test for the diagnosis of primary aldosteronism
por: Terui, Ken, et al.
Publicado: (2016)

Association between higher urinary normetanephrine and insulin resistance in a Japanese population
por: Murabayashi, Masaya, et al.
Publicado: (2020)

Cushing’s disease
por: Castinetti, Frederic, et al.
Publicado: (2012)

Cushing’s Disease
por: Nishioka, Hiroshi, et al.
Publicado: (2019)

Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies
por: Abusrair, Ali H., et al.
Publicado: (2022)

New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
por: Fleseriu, Maria, et al.
Publicado: (2013)

Systemic therapy of Cushing’s syndrome
por: Eckstein, Niels, et al.
Publicado: (2014)

Differential Effects of Fkbp4 and Fkbp5 on Regulation of the Proopiomelanocortin Gene in Murine AtT-20 Corticotroph Cells
por: Kageyama, Kazunori, et al.
Publicado: (2021)

Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population
por: Kamba, Aya, et al.
Publicado: (2016)

A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances
por: Abdulla, Maheeba, et al.
Publicado: (2022)

Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion
por: Daimon, Makoto, et al.
Publicado: (2017)

A case of ectopic ACTH syndrome treated with intermittent administration of dopamine agonists
por: Sakihara, Satoru, et al.
Publicado: (2014)

Two Cases of Hypopituitarism Caused by Intrasellar Aneurysm
por: Kageyama, Kazunori, et al.
Publicado: (2019)

Treatment Options in Cushing’s Disease
por: Rizk, Ahmed, et al.
Publicado: (2012)

Modern imaging in Cushing’s disease
por: Bashari, W. A., et al.
Publicado: (2022)

A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease
por: Kuro-o, Makoto
Publicado: (2013)

Pituitary-Directed Therapies for Cushing’s Disease
por: Langlois, Fabienne, et al.
Publicado: (2018)

Association between serum prolactin levels and insulin resistance in non-diabetic men
por: Daimon, Makoto, et al.
Publicado: (2017)

Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
por: García-Díaz, Nuria, et al.
Publicado: (2021)

The Molecular Pathology of Cushing Disease: Are We Nearly There?
por: Grossman, Ashley B.
Publicado: (2017)

Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets
por: Hulin, Alexia, et al.
Publicado: (2018)

Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology
por: Dalakas, Marinos C.
Publicado: (2023)

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
por: Karantanos, Theodoros, et al.
Publicado: (2017)

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies
por: Mavragani, Clio P., et al.
Publicado: (2012)

Cushing disease in pediatrics: an update
por: Concepción-Zavaleta, Marcio José, et al.
Publicado: (2023)

Molecular Pathophysiological Mechanisms in Huntington’s Disease
por: Jurcau, Anamaria
Publicado: (2022)

Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification
por: Felix-Ilemhenbhio, Favour, et al.
Publicado: (2022)

Targeting the ERK pathway for the treatment of Cushing's disease
por: Zhang, Dongyun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4tik78ik2qsep1cap9u7nvp27l